All posts
-
What the hyperproduction of AI slop is doing to science
Over the past three years, generative artificial intelligence (AI) has had a profound impact on society. AI’s impact on human writing, in particular, has been enormous.
-
The hunt is on for a top executive for a new innovation district
According to talent scout Per Christensen, that is in charge of employment, this will certainly not be a “timeless chief executive officer function.”
-
Eli Lilly submits application for new weight-loss tablet
In November, Eli Lilly protected an FDA top priority testimonial coupon, making it possible for an increased testimonial of its application.
-
A booming stock market listing: Medline rises more than 25%
This likewise provides the firm, which is generally possessed by the exclusive equity funds Blackstone, Carlyle Team, and Hellman & Friedman, a market price of greater than US…
-
Novo Nordisk aims to regain the weight loss market
Novo Nordisk have to end up being a lot more consumer-oriented and assume even more like Amazon by supplying consumers the very same rate and versatility, according to chief execut…
-
DNB Carnegie cuts its estimates for Novo Nordisk’s future earnings
This is based upon weak energy heading right into 2026 and Novo Nordisk’s most recent rate arrangement with United States Head of state Donald Trump.
-
Medline completes largest IPO of the year
With the securities market listing, the United States clinical tool firm is valued at USD 39bn.
-
Sanofi acquires Alzheimer’s candidate for over USD 1 billion
Sanofi protects legal rights to Alzheimer’s prospect from South Korea’s Adel.
-
Expanding promising Leo Pharma product will be new SVP’s main task
In 2026, Marika Murto signs up with Leo Pharma’s exec board with duty for international item method, where she will certainly be charged with safeguarding development for the…
-
Pfizer delivers lackluster revenue forecast
The pharmaceutical giant expects to achieve revenue of USD 59.5-62.5 billion in 2026.
